Showing results (211-220 of 259) with videos related to
Sort By:
Pageof 26
Cancer Management and Research|June 11, 2026
Comparative Efficacy of Fosnetupitant and Fosaprepitant for Delayed Vomiting in Patients Receiving Irinotecan-Oxaliplatin Combination Chemotherapy: A Retrospective Propensity Score-Matched StudyKazuki Maeda, Kei Kawada, Toshinobu Hayashi, et al.The Plant Cell|April 23, 2015
The Tyrosine Aminomutase TAM1 Is Required for β-Tyrosine Biosynthesis in RiceJian Yan, Takako Aboshi, Masayoshi Teraishi, et al.Viruses|August 29, 2024
The Role of Wild Boar as Host of Japanese Encephalitis Virus in the Absence of Domestic PigsFuka Kikuchi, Ai Hayashi, Karen Yamada, et al.Internal Medicine (Tokyo, Japan)|November 3, 2017
High Titer of Acquired Factor V Inhibitor Presenting with a Pseudo-deficiency of Multiple Coagulation FactorsKeiichi Nakata, Shuji Ueda, Hitomi Matsunaga, et al.American Journal of Physiology. Endocrinology and Metabolism|March 28, 2022
Stimulation of Gs signaling in MC4R cells by DREADD increases energy expenditure, suppresses food intake, and increases locomotor activity in miceShigenobu Matsumura, Motoki Miyakita, Haruka Miyamori, et al.Journal of Cachexia, Sarcopenia and Muscle|April 14, 2026
Muscle Atrophy-Related Adverse Events of Antidiabetic Drug Classes: A Pharmacovigilance Analysis Using VigiBase DataShiho Ueta, Takahiro Niimura, Mitsuhiro Goda, et al.Neurochemistry International|September 22, 2024
Statins ameliorate oxaliplatin- and paclitaxel-induced peripheral neuropathy via glutathione S-transferaseFuka Aizawa, Haruna Kajimoto, Ami Okabayashi, et al.Drug Safety|April 27, 2023
Cardiovascular Toxicities Associated with Anaplastic Lymphoma Kinase Inhibitors: A Disproportionality Analysis of the WHO Pharmacovigilance Database (VigiBase)Takahiro Niimura, Koji Miyata, Hirofumi Hamano, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 3, 2025
Risk factors for clazosentan-induced fluid retention in subarachnoid hemorrhage from the Japanese adverse event databaseRie Ando-Matsuoka, Kei Kawada, Takahiro Niimura, et al.Anticancer Research|May 27, 2026
Fosnetupitant Versus Fosaprepitant for Delayed Vomiting Upon Irinotecan-Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal CancerKazuki Maeda, Sota Koyama, Kei Kawada, et al.Pageof 26